Dr. Eisbruch has led many investigations and published over 200 peer-reviewed papers involving chemo-irradiation combinations for head and neck cancer and the characteristics of the toxicity of therapy. He has also investigated and developed methods to reduce toxicity using physiologic and metabolic imaging in treatment planning, prognosis, and therapy assessment, and assessing the uncertainties related to and value of therapy adaptation. He was the principal investigator of the first RTOG IMRT study, 00-22.

Dr. Eisbruch's most recent research includes using functional MRI to guide RT intensification for poor prognosis head and neck patients, funded by the NIH.

Areas of Interest
Characterizing the toxicity of therapy of head and neck cancers and methods to reduce it by IMRT
Improving delineation of targets and normal organs, using physiologic and metabolic imaging in treatment planning, prognosis, and therapy assessment
Assessing the uncertainties related to and value of therapy adaptation in head and neck cancer
Clinical Interests
Chemo-radiotherapy of head and neck cancer